HEMA: A urine footprint of ethylene oxide
HEMA is a “mercapturic acid” biomarker your body creates after contact with ethylene oxide, a small, highly reactive gas used to sterilize many medical devices and in some industrial processes. When ethylene oxide enters the body (by inhalation, and less commonly ingestion or skin contact), it reacts and is detoxified via glutathione pathways. One of the downstream products is HEMA, which is excreted in urine. Labs typically measure HEMA in urine by LC‑MS/MS, often normalized to creatinine, and results mainly reflect recent exposure over the prior few days.
Why an invisible sterilizing gas is worth tracking
Why does this matter? Ethylene oxide is an epoxide that can alkylate DNA and proteins, a mechanism linked to genotoxicity and oxidative stress. At higher or sustained exposures, it has been associated with increased cancer risk in occupational settings, and it can irritate eyes and airways. Most people carry a low baseline from everyday background sources, and smokers generally show higher levels due to tobacco smoke. The compound does not bioaccumulate like heavy metals, but repeated exposure can keep the biomarker elevated. The balance to strike is awareness without alarm: HEMA helps translate an invisible gas into a tangible number you can track.
Ethylene oxide’s biology is straightforward: it’s small, it’s reactive, and it seeks out nucleic acids and proteins. Your body counters by conjugating it with glutathione, then shuttling those conjugates to the kidney for elimination. Measuring HEMA captures that detox footprint. A single value cannot diagnose disease, but it can differentiate a chance exposure (for example, a brief visit to a high‑traffic urban area or a smoky environment) from a pattern that suggests ongoing contact—like working near sterilization equipment or regularly handling recently sterilized products. That distinction matters if you’re troubleshooting headaches or throat irritation after certain shifts, noticing tingling or brain fog that clusters around workdays, or tracking how secondhand smoke at home influences your baseline.
When a HEMA check is especially informative
Testing can be especially informative during pregnancy planning or pregnancy, in early childhood environments, or for workers in healthcare, laboratories, and industrial sterilization where ethylene oxide is used. Public health agencies consider ethylene oxide a human carcinogen at sufficient exposures, so clarifying whether your day‑to‑day level is typical versus consistently elevated adds context to long‑term risk management. Just as important, timing and dilution influence interpretation: urine concentration varies with hydration, many labs creatinine‑normalize to reduce that effect, and a single spot sample offers a snapshot rather than a movie. Like a sleep score, trends and context tell the real story—repeating the test after a change in environment or products can confirm whether the needle is truly moving.
Reading a HEMA result
When values sit toward the low end of population ranges, it typically reflects limited recent ethylene oxide contact and a lower likelihood of short‑term system stress from this specific exposure. Baseline “background” is expected because small amounts can form endogenously and exist in urban air; nonsmokers outside of high‑exposure settings often live in this zone.
When values trend higher, it can indicate recent or ongoing exposure, with potential added load on detox pathways that rely on glutathione and the liver‑kidney axis. If symptoms arise, they’re most likely to be nonspecific—irritation of eyes or airways, headache, or neurologic tingling—especially in people with occupational or smoke‑related exposure. Interpreting a single elevated result is cautious work: timing, hydration, and repeated measures help separate a transient spike from a pattern.
What can move a HEMA number
Labs usually report HEMA using population‑based reference ranges, often creatinine‑normalized to account for urine concentration. For environmental toxins, lower is generally preferable when feasible, and interpretation improves when you know what happened in the 48–72 hours before your sample (work shifts, smoke exposure, proximity to sterilized goods) and when you repeat the test to see direction over time.
What to read alongside a HEMA result
Big picture, HEMA is most meaningful beside related context: other environmental biomarkers, tobacco smoke indicators, general health labs, and your lived environment. Over months, that mosaic distinguishes one‑off blips from persistent exposure and supports smarter, safer decisions with your clinician’s guidance.
FAQs
This test measures urinary 2‑hydroxyethyl mercapturic acid (HEMA), a mercapturic acid metabolite and biomarker of exposure to ethylene oxide. Because HEMA is produced by glutathione conjugation of ethylene oxide and rapidly excreted, its concentration reflects recent internal exposure from inhalation or other routes (e.g., occupational sterilization, industrial emissions, or tobacco smoke) and is used to estimate short-term internal dose of this reactive, genotoxic agent.
Testing for 2‑Hydroxyethyl mercapturic acid (HEMA) can be useful when you have reason to suspect recent exposure to ethylene oxide (EO) or want to quantify internal exposure; HEMA is the principal urinary mercapturic‑acid biomarker of EO and therefore reflects the body’s absorbed dose. Because EO is a genotoxic compound classified as a human carcinogen and is associated with reproductive and hematologic effects, measurable HEMA matters for health and longevity as an indicator of an exposure that can produce DNA/protein alkylation and long‑term disease risk.
Potential sources include industrial EO use (sterilization of medical equipment, chemical manufacturing), fumigation/processing of some foods or spices, residues from plastics/ethylene‑glycol production, tobacco smoke and combustion emissions. Possible health impacts from chronic EO exposure include increased cancer risk, reproductive effects and impacts on blood/immune systems. Testing helps clarify whether exposure has occurred, estimate recent internal dose, identify likely sources, and track whether mitigation (workplace controls, product changes, ventilation, behavior changes) is reducing body burden.
Who benefits most: workers in EO/sterilization/chemical or plastics industries and nearby residents, people with unexplained hematologic or systemic symptoms, individuals concerned about fertility or reproductive outcomes, and those optimizing detox capacity or longevity who want objective data to guide exposure‑reduction strategies.
Typically you should obtain a baseline HEMA test once to assess recent exposure; if levels are elevated, arrange periodic follow-up testing (as advised by your clinician) to monitor trends and response to interventions, and retest after lifestyle or environmental changes—for example, after changing household products or following detoxification efforts—to confirm exposure reduction or the need for further action.
Several factors can alter 2‑Hydroxyethyl mercapturic acid (HEMA) test results: timing of sample collection (levels change with time after exposure); recent exposure from food, air, water, or consumer products; individual metabolism and organ function (which affect formation and clearance); hydration and urinary dilution; and the sample type and handling (urine vs blood, collection and storage). Certain medications or supplements may also influence readings.
No special fasting is required for 2-Hydroxyethyl mercapturic acid (HEMA) testing.
Use a clean-catch urine sample (first-morning is ideal), avoid excessive fluids for 2–3 hours beforehand, and follow your lab’s collection instructions.
If the goal isn’t to capture very recent exposure, try to avoid smoking/secondhand smoke and other ethylene-oxide sources for 24–48 hours prior. Let your clinician know about current medications and occupational exposures.
HEMA testing is a reliable urinary biomarker for recent ethylene oxide exposure rather than a measure of long‑term body burden; because HEMA is formed and cleared relatively quickly, results primarily reflect exposure in the previous hours to a few days. When performed with validated mass‑spectrometry methods the test is sensitive and specific, but results should be interpreted as a short‑term exposure indicator rather than cumulative exposure.
Accuracy depends strongly on sample timing (time since exposure and whether a spot or 24‑hour sample was collected), the laboratory method (high‑quality LC‑MS/MS or GC‑MS assays give the best accuracy), and consistency in collection, storage, and creatinine or specific‑gravity correction. Poorly controlled preanalytical steps, alternative assay methods, or inconsistent sampling reduce reliability and can lead to misclassification of exposure.
References
- Kenwood, B. M., McLoughlin, C., Zhang, L., Zhu, W., Bhandari, D., De Jesús, V. R., & Blount, B. C. (2021). Characterization of the association between cigarette smoking intensity and urinary concentrations of 2-hydroxyethyl mercapturic acid among exclusive cigarette smokers in the National Health and Nutrition Examination Survey (NHANES) 2011-2016. Biomarkers, 26(7), 656-664. https://doi.org/10.1080/1354750X.2021.1970809
- Agency for Toxic Substances and Disease Registry. (2022). ToxGuide for ethylene oxide (CAS# 75-21-8). https://www.atsdr.cdc.gov/toxguides/toxguide-137.pdf
- Barr, D. B., Wilder, L. C., Caudill, S. P., Gonzalez, A. J., Needham, L. L., & Pirkle, J. L. (2005). Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environmental Health Perspectives, 113(2), 192-200. https://doi.org/10.1289/ehp.7337
- Kolman, A., Chovanec, M., & Osterman-Golkar, S. (2002). Genotoxic effects of ethylene oxide, propylene oxide and epichlorohydrin in humans: update review (1990-2001). Mutation Research, 512(2-3), 173-194. https://doi.org/10.1016/s1383-5742(02)00067-4
- Centers for Disease Control and Prevention. (n.d.). National Report on Human Exposure to Environmental Chemicals. https://www.cdc.gov/biomonitoring/resources/national-exposure-report.html






































.avif)

